MILLS ROBERT S 4
4 · TFF Pharmaceuticals, Inc. · Filed Dec 15, 2020
Insider Transaction Report
Form 4
MILLS ROBERT S
Director
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2020-12-11−22,794→ 219,719 totalExercise: $2.50From: 2019-04-06Exp: 2028-04-06→ Common Stock (22,794 underlying) - Exercise/Conversion
Common Stock
2020-12-11$2.50/sh+22,794$56,985→ 38,774 total - Sale
Common Stock
2020-12-11$14.58/sh−22,794$332,337→ 15,980 total
Footnotes (2)
- [F1]The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- [F2]40,000 shares of the option vested and became exercisable on April 6, 2019.